{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:52:05Z","timestamp":1787165525135,"version":"build-2736575974"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2011,11,17]],"date-time":"2011-11-17T00:00:00Z","timestamp":1321488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The purpose of this study was to describe antimicrobial utilization, consumption, indications and microbial resistance in a medical-surgical-trauma intensive care unit (ICU) of a teaching hospital to identify potential targets for antimicrobial stewardship.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a 30-day prospective observational study enrolling adults admitted to the ICU for at least 24 h and having received antimicrobial therapy. Primary endpoints included utilization as percentage use of antimicrobials by class and agent, consumption measured as days of therapy per 1000 patient days (DOT\/1000PD), indications for use and prescriber. Secondary endpoints included reasons for modifications to therapy and microbial resistance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key findings<\/jats:title>\n                    <jats:p>Eighty-three patients were screened and 61 enrolled, receiving 133 courses of antimicrobial therapy, mainly intravenously and prescribed by ICU staff. The most frequently prescribed agents were piperacillin\/tazobactam (20%), cefazolin (17%) and vancomycin (13%). The indications for therapy were empirical (50%), directed (27%) and prophylactic (23%). Overall consumption was 1368.54 DOT\/1000PD and was mainly attributed to empirical therapy (734.25). Prolonged durations were noted for carbapenems and for surgical prophylaxis. There were 86 therapy modifications involving indication (36), efficacy (25), safety (18) and route (7). Suboptimal or excessive dosing were common contributors to efficacy and safety modifications, respectively. Infections due to microorganisms with notable resistance included methicillin-resistant Staphylococcus aureus (5), Pseudomonas aeruginosa (1) and Streptococcus pneumoniae (1).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Antimicrobial utilization and consumption based on DOT\/1000PD were prospectively determined providing a comparator for other ICUs. Potential targets identified for antimicrobial stewardship initiatives include empirical therapy, treatment duration, dosing and route.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.2042-7174.2011.00176.x","type":"journal-article","created":{"date-parts":[[2011,11,17]],"date-time":"2011-11-17T07:47:54Z","timestamp":1321516074000},"page":"164-171","source":"Crossref","is-referenced-by-count":10,"title":["Antimicrobial use in a critical care unit: a prospective observational study"],"prefix":"10.1093","volume":"20","author":[{"given":"Christina L","family":"Candeloro","sequence":"first","affiliation":[{"name":"Department of Pharmacy Services, Virginia Commonwealth University Health System\/Medical College of Virginia Hospitals, Richmond, VA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne M","family":"Kelly","sequence":"additional","affiliation":[{"name":"Pharmacy Services, London Health Sciences Centre, London, ON, Canada"},{"name":"Critical Care Trauma Centre, London Health Sciences Centre, London, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elk","family":"Bohdanowicz","sequence":"additional","affiliation":[{"name":"Pharmacy Services, London Health Sciences Centre, London, ON, Canada"},{"name":"Critical Care Trauma Centre, London Health Sciences Centre, London, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio M","family":"Martin","sequence":"additional","affiliation":[{"name":"Critical Care Trauma Centre, London Health Sciences Centre, London, ON, Canada"},{"name":"Division of Critical Care, Department of Medicine, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Mari","family":"Bombassaro","sequence":"additional","affiliation":[{"name":"Pharmacy Services, London Health Sciences Centre, London, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,11,17]]},"reference":[{"key":"2021031107361978500_b1","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1128\/AAC.01538-07","article-title":"Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005\u20132006","volume":"52","author":"Zhanel","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"2021031107361978500_b2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00134-008-1237-y","article-title":"Surveillance of microbial resistance in European intensive care units: a first report from the Care-ICU programme for improved infection control","volume":"35","author":"Hanberger","year":"2009","journal-title":"Intensive Care Med"},{"key":"2021031107361978500_b3","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1378\/chest.117.5.1496","article-title":"Rational empiric antibiotic prescription in the ICU","volume":"117","author":"Singh","year":"2000","journal-title":"Chest"},{"key":"2021031107361978500_b4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/510393","article-title":"Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship","volume":"44","author":"Dellit","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2021031107361978500_b5","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1086\/511640","article-title":"Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy","volume":"44","author":"Polk","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2021031107361978500_b6","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1001\/archinte.168.20.2254","article-title":"Trends in antibacterial use in US academic health centers 2002 to 2006","volume":"168","author":"Pakyz","year":"2008","journal-title":"Arch Intern Med"},{"key":"2021031107361978500_b7","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2125.2006.02605.x","article-title":"Discrepancies between prescribed daily doses and WHO defined daily doses of antibacterials at a university hospital","volume":"61","author":"Muller","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"2021031107361978500_b8","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1086\/344753","article-title":"The effect of renal dysfunction on antimicrobial use measurements","volume":"35","author":"Zagorski","year":"2002","journal-title":"Clin Infect Dis"},{"key":"2021031107361978500_b9","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1097\/00003246-199510000-00007","article-title":"Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome","volume":"23","author":"Marshall","year":"1995","journal-title":"Crit Care Med"},{"key":"2021031107361978500_b10","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1086\/652152","article-title":"Multidrug resistance among gram-negative pathogens that caused healthcare-associated infections reported to the National Healthcare Safety Network, 2006\u20132008","volume":"31","author":"Kallen","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2021031107361978500_b11","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1001\/jama.2009.1754","article-title":"International study of the prevalence and outcomes of infection in intensive care units","volume":"302","author":"Vincent","year":"2009","journal-title":"JAMA"},{"key":"2021031107361978500_b12","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jhin.2007.04.008","article-title":"Point prevalence survey for healthcare-associated infections within Canadian adult acute-care hospitals","volume":"66","author":"Gravel","year":"2007","journal-title":"J Hosp Infect"},{"key":"2021031107361978500_b13","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/clinids\/18.3.422","article-title":"Quality standard for antimicrobial prophylaxis in surgical procedures. Infectious Diseases Society of America","volume":"18","author":"Dellinger","year":"1994","journal-title":"Clin Infect Dis"},{"key":"2021031107361978500_b14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/sur.2009.047","article-title":"Critical analysis of empiric antibiotic utilization: establishing benchmarks","volume":"11","author":"Claridge","year":"2010","journal-title":"Surg Infect (Larchmt)"},{"key":"2021031107361978500_b15","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.1128\/AAC.48.12.4718-4724.2004","article-title":"Pharmacodynamic profiling of piperacillin in the presence of tazobactam in patients through the use of population pharmacokinetic models and Monte Carlo simulation","volume":"48","author":"Lodise","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"2021031107361978500_b16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2146\/ajhp080434","article-title":"Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists","volume":"66","author":"Rybak","year":"2009","journal-title":"Am J Health-Syst Pharm"},{"key":"2021031107361978500_b17","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jcrc.2008.10.004","article-title":"Epidemiology of Staphylococcus aureus nasal colonization and influence on outcome in the critically ill","volume":"24","author":"Niven","year":"2009","journal-title":"J Crit Care"},{"key":"2021031107361978500_b18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/archinte.163.2.181","article-title":"Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus at admission to the intensive care unit: results of a multicenter study","volume":"163","author":"Lucet","year":"2003","journal-title":"Arch Intern Med"},{"key":"2021031107361978500_b19","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1086\/510622","article-title":"Improving methicillin-resistant Staphylococcus aureus surveillance and reporting in intensive care units","volume":"195","author":"Huang","year":"2007","journal-title":"J Infect Dis"}],"container-title":["International Journal of Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.2042-7174.2011.00176.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ijpp\/article-pdf\/20\/3\/164\/36526043\/j.2042-7174.2011.00176.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ijpp\/article-pdf\/20\/3\/164\/36526043\/j.2042-7174.2011.00176.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T03:48:58Z","timestamp":1615434538000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijpp\/article\/20\/3\/164\/6102286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,17]]},"references-count":19,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2011,11,17]]},"published-print":{"date-parts":[[2018,6,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.2042-7174.2011.00176.x","relation":{},"ISSN":["2042-7174","0961-7671"],"issn-type":[{"value":"2042-7174","type":"electronic"},{"value":"0961-7671","type":"print"}],"subject":[],"published-other":{"date-parts":[[2012,6]]},"published":{"date-parts":[[2011,11,17]]}}}